We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVA icon
976
Avista
AVA
$3.24B
$1.14M 0.01%
31,278
+3,308
+12% +$131K
TRIP icon
977
TripAdvisor
TRIP
$1.29B
$1.14M 0.01%
59,833
-479
-0.8% -$9.15K
DINO icon
978
HF Sinclair
DINO
$16.3B
$1.14M 0.01%
38,951
+679
+2% +$20.2K
SPSC icon
979
SPS Commerce
SPSC
$2.86B
$1.14M 0.01%
15,132
BFH icon
980
Bread Financial
BFH
$4.51B
$1.14M 0.01%
31,541
+18,303
+138% +$651K
DVN icon
981
Devon Energy
DVN
$48.8B
$1.14M 0.01%
100,090
+336
+0.3% +$3.83K
CCXI
982
DELISTED
ChemoCentryx, Inc.
CCXI
$1.13M 0.01%
19,706
+1,826
+10% +$99.4K
LPSN icon
983
LivePerson
LPSN
$35.9M
$1.13M 0.01%
1,812
NBL
984
DELISTED
Noble Energy, Inc.
NBL
$1.12M 0.01%
125,458
+2,171
+2% +$19.4K
CROX icon
985
Crocs
CROX
$6.36B
$1.12M 0.01%
30,418
+1,900
+7% +$50.3K
OVV icon
986
Ovintiv
OVV
$17.2B
$1.12M 0.01%
+117,276
New +$818K
APPF icon
987
AppFolio
APPF
$7.22B
$1.12M 0.01%
6,877
FOX icon
988
Fox Class B
FOX
$24.4B
$1.12M 0.01%
41,651
-200
-0.5% -$5.32K
GDOT icon
989
Green Dot
GDOT
$770M
$1.11M 0.01%
22,692
+1,176
+5% +$39.8K
RIG icon
990
Transocean
RIG
$6.39B
$1.11M 0.01%
608,569
+278,426
+84% +$433K
EHTH icon
991
eHealth
EHTH
$38.8M
$1.11M 0.01%
11,336
+1,600
+16% +$186K
URBN icon
992
Urban Outfitters
URBN
$6.53B
$1.11M 0.01%
72,975
+32,484
+80% +$557K
NCLH icon
993
Norwegian Cruise Line
NCLH
$8.98B
$1.1M 0.01%
67,043
+12,202
+22% +$179K
HLI icon
994
Houlihan Lokey
HLI
$9.24B
$1.1M 0.01%
19,704
+1,569
+9% +$91.4K
DXC icon
995
DXC Technology
DXC
$1.79B
$1.1M 0.01%
66,364
+378
+0.6% +$6.01K
ORA icon
996
Ormat Technologies
ORA
$6.98B
$1.09M 0.01%
17,241
+783
+5% +$51.2K
CVBF icon
997
CVB Financial
CVBF
$4.08B
$1.09M 0.01%
58,337
+1,919
+3% +$36.6K
WMS icon
998
Advanced Drainage Systems
WMS
$11.3B
$1.08M 0.01%
21,815
+3,125
+17% +$128K
OLN icon
999
Olin
OLN
$2.17B
$1.08M 0.01%
93,740
+2,087
+2% +$26.6K
MMSI icon
1000
Merit Medical Systems
MMSI
$5.4B
$1.08M 0.01%
23,561

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.